Autolus Therapeutics (AUTL)
NASDAQ: AUTL
· Real-Time Price · USD
1.28
0.06 (4.92%)
At close: May 15, 2025, 3:19 PM
Autolus Therapeutics Revenue
Autolus Therapeutics reported an annual revenue of $10.12M, reflecting a 496% growth. For the quarter ending March 31, 2025, Autolus Therapeutics generated $8.98M in revenue.
Revenue (ttm)
$10.12M
Revenue Growth
496%
Price / Sales Ratio
59.25
Revenue / Employee
$15.64K
Employees
647
Market Cap
341.99M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|